Wen Cai

529 citations
17 papers · 447 indexed · h-index 13
Topics
Cancer therapeutics and mechanisms (9 papers)Bioactive Compounds and Antitumor Agents (8 papers)Synthesis and Biological Activity (3 papers)
Partner nations
United StatesChina

In The Last Decade

Wen Cai

16 papers receiving 426 citations

Peers

Wen Cai
Comparison fields: 5 of 67
  • Organic Chemistry 270
  • Molecular Biology 225
  • Toxicology 151
  • Cancer Research 53
  • Pharmacology 49
Replace Yeh-Long Chen with:
Yeh-Long Chen Taiwan
Sebastiano Marciani Magno Italy
Dmitry N. Kaluzhny Russia
Christelle Marminon France
Marie A. Colucci United Kingdom
Paolo Manzini Italy
Viswanath Arutla India
Balu Balasubramanian United States
Zhuang Hou China
Changkun Hu United States
Wen Cai relative to Yeh-Long Chen Taiwan Yeh-Long Chen's profile →
Citations per field
00.5×1.5×
Yeh-Long Chen · 1×
Citations per year

Countries citing papers authored by Wen Cai

Since Specialization
Citations

This map shows the geographic impact of Wen Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Cai more than expected).

Fields of papers citing papers by Wen Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Cai. The network helps show where Wen Cai may publish in the future.

Co-authorship network of co-authors of Wen Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Cai. A scholar is included among the top collaborators of Wen Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Cai. Wen Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 9
2 2
3 15
4 9
5 36
6 38
7 12
8 39
9 71
10 20
11
Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin.
26
12 26
13 31
14 0
15 39
16 47
17 27

About Wen Cai

Wen Cai is a scholar working on Toxicology, Cancer Research and Virology, having authored 17 papers that have together received 447 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Synthesis and Biological Activity (3 papers). The work is most often cited by research in Toxicology (151 citations), Organic Chemistry (270 citations) and Cancer Research (53 citations). Wen Cai has collaborated with scholars based in United States and China. Frequent co-authors include Mohammad Behforouz, Zhengxiang Gu, Jalal Haddad, Howard D. Beall, Jayana P. Lineswala, Hassan Seradj, David C. Holley, John M. Gerdes, M. Brian Arnold and Kenneth D. Burman. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026